tirzepatide glp 1 drops reviews There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests Retatrutide for weight loss: Study

And yet, when we look back through patient notes, the same patterns turn up over and over

2022;34(1):59e7410

In trials for tirzepatide, patients lost an average of nearly 21% of their body weight in 36 weeks

Some people might experience digestive discomfort if they consume too much too quickly

Patients using these medicines may experience markedly reduced appetite and food intake, which could in susceptible individuals lead to inadequate consumption of animal-derived foods, the primary dietary sources of vitamin B12

Although conclusive studies are still being conducted, tirzepatide may provide even more advantages due to its increased potency and dual-receptor mechanism